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Abstract 
The expression of mRNA for the inducible form of nitric oxide synthase, (iNOS), was studied in rat aortic smooth muscle cells, (SMCs) in cell 
culture and in strips of rat aorta by reverse transcriptase coupled to the polymerase chain reaction. iNOS mRNA expression was weak in cultured 
SMCs when exposed to either interferon-y (IFN,) or lipopolysaccharide (LPS), but the combination LPS + IFN, enhanced the expression. In aortic 
strips LPS alone induced a pronounced expression, with no further increase by IFN,. Cycloheximide potentiated the expression of iNOS mRNA 
in SMCs in culture stimulated with LPS + IFN, but attenuated the response in aortic strips.The results indicate different cellular signahng pathways 
for the induction of iNOS mRNA by LPS and/or IFN,, in cultured SMCs and in rat aortic strips. 
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1. Introduction 
During severe experimental and clincal septicaemia 
the resistance vessels of the vascular bed paradoxically 
relax, showing a reduced sensitivity to vasoconstrictors, 
causing progressive hypoperfusion and irreversible 
shock. This occurs in about 35% of all septicaemia pa- 
tients in emergency care. Its cause has been suggested to 
be due to a sustained production of nitric oxide in the 
vascular resistance vessels [l-3]. Administration of L- 
arginine analogs that block nitric oxide synthesis, both 
experimentally, in dogs after treatment with tumor ne- 
crosis factor (TNFa) [4], in rats after E. coli lipopolysac- 
charide (LPS) [5], and clinically in man [3,6], block this 
vasodilatation and restore the vascular smooth muscle 
contractile response to vasopressors [7,8]. Thus, the in- 
ducible form of nitric oxide synthase, iNOS, is expressed 
in the cells of many organs and in the vascular wall after 
exposure to LPS or to various cytokines, as demon- 
strated in vitro in endothelial cells [9,10], macrophages 
[ 11,121, rat renal tubular cells [ 131 and human mesangial 
cells [14]. It has also been shown in vitro that vascular 
*Corresponding author. Fax: (46) (13) 12 74 65. 
Abbreviations: iNOS, inducible nitric oxide synthase; SMC, smooth 
muscle cell; RT, reversed transcription; PCR, polymerase chain reac- 
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smooth muscle cells (SMCs) from rat aorta [15] and rat 
pulmonary artery [16] produce NO after exposure to 
cytokines and it was thus inferred that cytokines induce 
iNOS gene expression in vascular smooth muscle cells 
generally in resistance vessels [8]. 
The inducible form of NOS has recently been cloned 
from murine macrophages [17-191, rat vascular SMCs 
[20] and human hepatocytes [21] and has been identified 
as an approximately 4.4-kilobase mRNA on Northern 
blot analysis. 
However, mature SMCs in the aortic wall and prolifer- 
ating SMCs in culture express different phenotypes, con- 
tractile vs. synthetic [22]. The latter phenotype expresses 
growth factors that could possibly modulate the iNOS 
induction by LPS and cytokines [23-261. Thus, results 
from studies of iNOS gene expression by cytokines in the 
synthetic phenotype may not be identical to the iNOS 
expression by cytokines in mature, non-cycling SMCs in 
the vasculature during clinical septicaemia. 
To investigate this we have studied iNOS mRNA ex- 
pression in rat aortic SMCs in cell culture and in strips 
of rat aorta, in vitro, after exposure to either LPS or 
interferon-y (IFN,) or to both. 
Our results disclose a difference in iNOS induction in 
synthetic, proliferating rat SMCs in culture and in ma- 
ture smooth muscle cells in the rat aortic wall after expo- 
sure to cytokines and endotoxin in vitro. Thus, results 
from investigations of cultured SMCs in vitro may not 
simply be extrapolated to the clinical situation. 
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2. Materials and methods 
E. coli Lipopolysaccharide endotoxin, actinomyocin D, cyclo- 
heximide, collagenase and ascorbic acid were all purchased from Sigma 
Chemicals (St Louis, MO, USA). Recombinant murine interferon-y 
came from PharMingen (San Diego, CA, USA). Dexamethasone came 
from Calbiochem Corp (La Jolla, CA, USA), gentamycin sulphate, 
fungizone, fetal calf serum and L-glutamine were all purchased from 
Gibco Ltd (Renfrewshire, Scotland). Trypsin was purchased from 
Difco Lab (Detroit, MI, USA). All plastic labware was purchased from 
Costar Europe (Badhoevedorp, The Netherlands). Taq DNA polym- 
erase came from Promega (Madison, WI, USA) and M-MLV reverse 
transcriptase from Gibco BRL (USA). 
2.1. Preparation and culture of vascular smooth muscle cells and strips 
of aorta 
The SMCs were prepared according to Thyberg et al. [27]. Aortas of 
adult Sprague-Dawley rats were stripped of adventitia, the endothelial 
cell layer of the intima was scraped off and the aorta was cut into small 
pieces and digested with 0.1% collagenase for one hour. The collagenase 
solution was exchanged for fresh collagenase and the aortic pieces were 
further digested for 1620 h at 37°C. The digest was passed through 
a nylon filter. The cells were centrifuged and washed three times in 
complete medium and seeded out in 75 cm’ flasks. The SMCs were 
grown in Ham’s F-12 medium, supplemented with ascorbic acid (50 
pg ml-‘), gentamycin sulphate (50 pg . ml-‘), fungizone 
(2.5 fig ml-‘), L-glutamate (100 pg . ml-‘) and 10% fetal calf serum. 
The flasks were kept at 37°C in an atmosphere of 5% CO* in humidified 
air (Forma Scientific Incubator). 
Confluent cell cultures were treated with 0.25% trypsin in Ca*‘- and 
Me-free phosphate-buffered saline solutions containing 0.02% 
EDTA. The cells were washed three times with medium and seeded out 
in 100 mm* plates, in which they were cultured to confluence in Ham’s 
F12 medium containing 10% calf serum in an atmosphere of 5% CO, 
in humidified air at 37°C Cultures at passage 4 to 10 were used for 
the experiments. 
Confluent cultures of SMCs were incubated for 12 h with medium 
containing 5% fetal calf serum at 37°C before and during the treatment 
with the different agents, as given in the legends to figures. 
Strips of aorta were prepared from excised aortic sections of male 
Spraque-Dawley rats, where the intima and the adventitia were 
stripped off by dissection. After excision, the aortic strips were incu- 
bated and treated the same as the cultured SMCs as described above. 
Figs. l-6 shows representative r sults from 3-5 independent experi- 
ments. 
2.2. Preparation and isolation of RNA 
Total RNA was prepared from SMCs and aortic strips using the 
guanidinium/phenol/chloroform method [28]. The RNA concentration 
and purity were estimated from the optical density at 260 nm and 
280 nm (Perkin-Elmer, lambda 2 UV/Vis spectrophotometer). 
2.3. Reversed transcription-polymerase chain reaction 
Two pug of total RNA from each sample was reversely transcribed 
(RT) into cDNA by incubating with 1flM oligo (dT),, primer, 3 mM 
MgCI,, 400 U murine Moloney leukemia virus reverse trancriptase, 
500 PM dNTP, 0.01 mM dithiothreitiol, 75 mM KC1 and 50 mM 
Tris-HCl pH 8.3 in a final volume of 20 ~1 at 37°C for 1 h. 
The cDNA was amplified by the polymerase chain reaction (PCR) 
in a 40 ~1 reaction containing 100 ng of transcribed total RNA, 1.25 
U of Taq DNA polymerase (Promega, Madison, WI, USA), 0.5 PM 
of primers and 1.5 mM MgCl, in 1 x reaction buffer provided by the 
supplier (Promega). Amplification was performed in a Perkin-Elmer 
Thermal Cycler; with initial heating for 1 min at 94°C followed by 
25 cycles of 1 min at 94°C 1 min at 60°C 2 min at 72°C and a final 
extension for 7 min at 72°C. 
Ten ~1 of the reaction mixture was mixed with loading buffer and 
separated by electrophoresis on 1.2% agarose gels containing ethidium 
bromide (0.5 &ml) and visualized by UV transillumination. 
2.4. PCR-primers 
cDNA from each sample was amplified with specific primers for 
iNOS and glyceraldehyde-3-phosphate dehydrogenase (GAPDH) in 
separate tubes. The upstream and downstream primers for iNOS were: 
5’-CCCTTCCGAAGTTTCTGGCAGCAG-3’ and S-GGGCTCC- 
TCCAAGGTGTTGCCC-3’, respectively, and gave a single band cor- 
responding to a 473 base pair fragment from position 2973 to 3446 in 
rat iNOS cDNA, [20]. 
The upstream and downstream primers for GAPDH were; 5’-AC- 
CACAGTCCATGCCATCAC-3’and 5’-TCCACCACCCTGTTGC- 
TGTA-3’, respectively. These yielded a single PCR-product cor- 
resonding to a 452 base pair fragment from position 5861068 in the 
rat GAPDH cDNA and the primers were purchased from Clontech 
Laboratories, Inc. (Palo Alto, CA, USA). 
2.5. Determination of nitrite 
Nitric oxide production was assessed measuring its stable end prod- 
uct, nitrite, in the culture medium using a modification of Bell’s method 
[29]. This method utilizes the diazotation of sulfanilic acid by nitrite at 
an acidic pH and its coupling to N-(1-naftyl)-ethylendiamine. Media 
from SMC cultures exposed to the different treatments were incubated 
with 1.0 mM sulfanilic acid, 0.4 M HCl and 0.5 mM N-(l-naftyl)- 
ethylendiamine at room temperature for 30 min and the coloured reac- 
tion product was quantitated at 548 nm (Beckman DU 68, spectro- 
photometer). 
3. Results 
Amplification of cDNA from cultured SMCs with spe- 
cific iNOS primers generated a faint PCR-product of the 
predicted size, 473 bp, after exposure for 8 h to IFN, or 
LPS as illustrated in Fig. 1. However, exposure of SMCs 
for 8 h to a combination of IFN, + LPS revealed a pro- 
nounced increase in iNOS mRNA (Fig. 1). 
Amplification of the same reversely transcribed RNA 
with primers specific for GAPDH was used as a control 
for equal RT-PCR processing and loading of samples 
(Figs. 1 and 3-6). RNA samples that were not processed 
with reverse transcriptase gave no detectable PCR prod- 
uct (results not shown). 
In order to verify iNOS induction, we measured its 
activity by determination of nitrite, NO;, the end me- 
tabolite of nitric oxides, in the culture media. As shown 
in Fig. 2, neither single exposure to IFN, nor LPS alone 
iNOS 
Fig. 1. Expression of iNOS mRNA in SMCs. Total RNA was isolated 
from SMCs and analyzed by the RT-PCR to measure the iNOS (upper 
panel) and GAPDH (lower panel) mRNA levels as described in Mate- 
rials and Methods. An aliquot of the RT-PCR-amplified RNA from 
untreated cells (CON) or cells exposed for 8 hto 5pg LPS t ml-’ medium 
(LPS), 300 U INFg ml-’ medium (IFN,) or 5 .ug LPS + 300 U 
IFN, ml-’ medium (LPS/IFN,) was separated on a 1.2% agarose gel 
and stained with ethidium bromide for comparison. 
A. Sirsj6 et al. IFEBS Letters 338 (1994) 191-196 193 
INFyfLPS + CH 
b 
INFy/LP!S + DEX 
7. ..,I... I”’ “““““I”“’ 
0 0.5 1 1.5 2 2.5 3 3.5 4 
MM 
Fig. 2. Nitrite production by SMCs. Nitrite was measured as described 
in section 2 in medium from control cells (CON) and in medium where 
cells were exposed for 8 h to 5 pg LPS ml-’ medium (LPS), 300 U 
IFN, . ml-’ medium (IFN,), 5 fig LPS + 300 U INFg ml-’ 
medium (LPSI IFN,), 5 fig LPS + 300 U IFN, ml-’ medium together 
with 50 PM cycloheximide (LPSIIFN, + CH) or 0.5 PM dexam- 
ethasone (LPS/IFN, + DEX). Mean + S.D., n = 4. 
induced any detectable increase of nitrite in the culture 
media following 8 h of exposure. However, when the 
SMCs were incubated with a combination of 
LPS + IFN,, a significant increase of nitrite was found 
in the media (Fig. 2). 
iNOS mRNA induction was seen as early as after 4 h 
exposure to LPS + IFN, and the induction was futher 
enhanced at 8, 16, 24 h and still remained high at 36 h 
(Fig. 3). 
To assess the role of on-going protein synthesis for the 
induction of iNOS mRNA in cultured SMCs after expo- 
sure to LPS + IFN,, the cells were exposed to the protein 
synthesis inhibitor cycloheximide. The expression of 
mRNA for iNOS increased after addition of cyclo- 
heximide together with LPS + IFN, compared to the 
combination LPS + IFN, alone (Fig. 4). Furthermore, 
cycloheximide completely inhibited the LPS + IFN, in- 
duced nitrite accumulation in the media (Fig. 2), con- 
Fig. 3. Time course of induction of iNOS mRNA in SMCs. Total RNA 
was isolated from SMCs and analysed by the RT-PCR to measure the 
iNOS (upper panel) and GAPDH (lower panel) mRNA levels as de- 
scribed in section 2. An aliquot of the RT-PCR-amplified RNA from 
cells treated with 5 pg LPS + 300 U IFN, ml-’ medium for 0,4, 8, 16, 
24, or 36 h was separated on a 1.2% agarose gel and stained with 
ethidium bromide for comparison. 
firming the effectiveness of cycloheximide in blocking 
protein synthesis. 
Addition of actinomycin D, an RNA synthesis inhibi- 
tor, to the combined inducer LPS + IFN, extinguished 
the induction entirely (Fig. 4). These findings suggest 
that the expression of iNOS in SMCs by LPS + INFg is 
transcriptionally regulated. 
Several reports in the literature have demonstrated the 
inhibition of NO synthesis by glucocorticoids [10,30]. 
The results shown in Fig. 4 demonstrate that dexa- 
methasone decreased the LPS + IFN, induction of 
mRNA for iNOS and almost completely inhibited the 
accumulation of nitrite in the media (Fig. 2). 
To mimic an in vivo situation, we exposed excised 
tissue strips of rat aorta in organ culture to IFN, or LPS 
alone or in combination. IFN, alone gave no induction 
of iNOS mRNA, but the combined exposure to 
LPS + IFN, induced a significant expression of iNOS 
mRNA by SMCs (Fig. 5). In contrast to cultured SMCs, 
LPS alone induced iNOS mRNA to approximately the 
same extent as the combined treatment with LPS + IFN, 
(Fig. 5) 
The effects of cycloheximide on the induction of 
mRNA for iNOS by LPS and LPS + INFg in the aortic 
tissue strips is shown in Fig. 6. Cycloheximide attenuated 
the induction both by LPS alone and by the combination 
of LPS + IFN,. This indicates that the induction of 
mRNA for iNOS in aortic tissue strips by LPS and by 
LPS + IFN, requires a certain de novo protein synthesis, 
not found necessary for the induction in cultured SMCs. 
In agreement with the results obtained with cultured 
SMCs, dexamethasone also decreased the induction of 
iNOS mRNA by LPS and LPS + IFN, in the aortic 
iNOS 
GAPDH 
5M)bp 
mbp 
Fig. 4. Effects of cycloheximide, actinomycin D or dexamethasone on 
the expression of iNOS mRNA in SMCs. Total RNA was isolated from 
SMCs and analyzed by the RT-PCR to measure the iNOS (upper panel) 
and GAPDH (lower panel) mRNA levels as described in section 2. An 
aliquot of the RT-PCR-amplified RNA from untreated cells (CON) or 
cells exposed for 8 h to 5 pg LPS + 300 U IFN, ml-’ medium alone 
(LPS/IFN,) or together with 50 PM cycloheximide (LPSIIFN, + CH), 
4 PM actinomycin D (LPS/IFN, + AD) or 0.5 PM dexamethasone 
(LPS/INFg + DEX)was separated on a 1.2% agarose gel and stained 
with ethidium bromide for comparison. 
194 
Fig. 5. Expression of iNOS mRNA in tissue strips of aorta. Total RNA 
was isolated from strips of aorta and analyzed by the RT-PCR to 
measure the iNOS (upper panel) and GAPDH (lower panel) mRNA 
levels as described in section 2. An aliquot of the RT-PCR-amplified 
RNA from untreated strips of aorta (CON) or after 6 h exposure to 5 
lug LPSm-’ medium (LPS), 300 U 1FN;mlI medium (IFN,) or 5 pg 
LPS + 300 U IFN;ml-’ medium (LPS/IFN,) was separated on a 1.2% 
agarose gel and stained with ethidium bromide for comparison. 
strips (Fig. 6). Under these experimental conditions we 
were unable to detect any nitrite accumulation in the 
culture media from aortic strips (results not shown). 
4. Discussion 
In this study we have demonstrated that vascular 
smooth muscle cells have the ability to express mRNA 
for the macrophage-type of inducible nitric oxide syn- 
thase, which has also been shown by others [20,31]. How- 
ever, regulation of NO production may differ between 
different phenotypic forms of SMCs. Whereas SMCs in 
arterial wall media do express a contractile phenotype 
with an abundance of microfilaments, proliferating 
SMCs in vitro, originating and isolated from arteries, do 
express a so-called synthetic phenotype, with a higher 
volume fraction of cell organelles for de novo protein 
synthesis and supposedly thereby express growth and 
transcription factors [22]. 
The exact difference in sensitivity to inducing cytoki- 
nes and possibly also in signal cross-talk between the 
signal transduction mechanisms in mature smooth mus- 
cle cells in tissue strips and in replicating SMCs in vitro 
still needs to be clarified. 
However, our results suggest some caution when ex- 
trapolating in vitro results from cultures of SMCs to a 
clinical situation. 
IFN, alone did induce a weak expression of mRNA 
for iNOS but no NO synthesis in replicating SMCs in 
culture, the latter measured as nitrite in the medium. This 
is in conformity with recent findings [16, 321 in cultured 
SMCs. 
Several studies have reported that exposure of aortic 
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rings denuded of endothelial cells in vitro to LPS alone 
induces NO production [30], which is in agreement with 
our results at mRNA level. To our knowledge there are 
no studies addressing the ability of IFN, to induce NO 
production and subsequent relaxation of aortic rings in 
vitro. Our results indicate however, that INFg is not 
required for the induction of iNOS mRNA in vascular 
smooth muscle cells in vivo, i.e. in situations such as 
septic shock. 
The promotor region of the mouse gene encoding 
iNOS was recently cloned and shown to contain response 
elements and inducibility by IFN, and LPS [33]. In view 
of these results it seems likely that the observed differ- 
ence in response to IFN, between cultured SMC’s and 
aortic strips could be explained by differences in the 
number of INFg-receptors and/or differences in intracel- 
lular singnaling between mature SMCs in the vessel wall 
and in cultures. In agreement with previous in vitro stud- 
ies on endothelial cells [lo], macrophages [34] and hepa- 
tocytes [35] we have demonstrated that dexamethasone 
attenuated the expression of iNOS mRNA and subse- 
quent NO synthesis in cultured SMCs and in SMCs in 
aortic tissue strips in vitro after exposure to LPS alone 
or to LPS + INFg. As has been suggested by others 
[30,35] , this seems to be the therapeutic mechanism by 
which glucocorticoids eliminate the hypotension and cir- 
culatory collapse during clinical septic shock. Our results 
demonstrated a major difference in the effects of cyclo- 
iNOS 
GAPDH 
Fig. 6. Effects of cycloheximide or dexamethasone on expression of 
iNOS mRNA in tissue strips of aorta. Total RNA was isolated from 
strips of aorta and analyzed by the RT-PCR to measure the iNOS 
(upper panel) and GAPDH (lower panel) mRNA levels as described in 
section 2. An aliquot of the RT-PCR-amplified RNA from untreated 
strips of aorta (CON) or after 6 h exposure to 5 pug LPSml’ medium 
(LPS), 5 pug LPS+300 U IFN;ml- medium (LPS/IFNr), 5 fig LPSmll’ 
medium together with 50 PM cycloheximide (LPS + CH), 5 pg LPS + 
300U INFgml-’ medium together with 50 PM cycloheximide (LPS/ 
IFN, + CH), 5 pg LPSm-’ medium together with 0.5 PM dexam- 
ethasone (LPS + DEX) and 5 pg LPS + 300 U IFN;mll’ medium 
together with 0.5 PM dexamethasone (LPS/IFN, + DEX) was sepa- 
rated on a 1.2% agarose gel and stained with ethidium bromide for 
comparison. 
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heximide on iNOS mRNA induction between SMCs in 
culture and mature SMCs in aortic tissue strips. 
In the former, cycloheximide together with LPS + 
IFN, increased the induction levels of iNOS mRNA, in 
comparison to the induction with LPS + IFN,. This im- 
plicates the involvement of either constitutively ex- 
pressed labile repressor protein(s) and/or RNases. 
The cyclohexemide-dependent i duction has also been 
demonstrated in mouse peritoneal macrophages for the 
genes induced by interferon-y, TNFa, interleukin-1 and 
urokinase [36]. LPS and cycloheximide induction have 
also been described for the melanoma growth stimula- 
tory activity factor gene [37], the type 1 plasminogen 
activator inhibitor gene [38] and the manganese superox- 
ide dismutase gene [39]. In aortic tissue strips cyclo- 
heximide attenuates the induction seen by LPS alone or 
by LPS + IFN,. This indicates that the induction of 
iNOS mRNA in SMCs in aortic tissue strips requires de 
novo protein synthesis, protein(s) or transcription fac- 
tors that seems to be constitutively expressed in SMCs 
in culture. ATTTA sequences are present in the iNOS 
cDNA of murine macrophages [17-l 91 and human hepa- 
tocytes [21], that have been implicated to confer instabil- 
ity to the transcriptional regulation of gene expression by 
many cytokines, protooncogenes and transcription fac- 
tors [40,41]. However, ATTTA sequences have not been 
found in rat iNOS cDNA [20]. This might imply that the 
rat iNOS cDNA was incomplete, which could explain the 
effects of cycloheximide in this study. However, mRNA 
instability would also prevail if the synthetic SMC type 
implied higher levels of specific or non-specific RNases 
compared to the non-replicating SMCs in aortic strips. 
However, we cannot exclude the possibility that the dif- 
ferences found could also be dependent on contributions 
from contaminating non-smooth muscle cells within the 
aortic strips. Electron microscopic [42] and histologic 
[43] studies have demonstrated the presence of a substan- 
tial population of lymphocytes and monocytes within the 
aortic intima. 
In conclusion, our results indicate for different re- 
quirements for iNOS mRNA induction in rat smooth 
muscle cells in culture and in mature smooth muscle cells 
in aortic strips in organ culture. These differences impose 
a certain restriction to the extrapolation of clinical condi- 
tions that may be drawn from in vitro experiments with 
proliferating smooth muscle cells in culture. 
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